Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Endothelial dysfunction.php on line 2
Endothelial dysfunction
LE WE PMID CA
Endothelial dysfunction804Endotheliale Dysfunktion

5 10 methylenetetrahydrofolate reductase MTHFR

Aldosterone

Allopurinol

AMP activated protein kinase

Arterial hypertension (BASKET)

Asymmetric dimethylarginine

Atherosclerosis (peripheral vessels)

Blood vessels (Permeability)

Blood vessels (Physiology)

Cardiorenal syndrome

Cardiovascular risk

Caveolin and caveoles

Cell stress (ER stress)

Cystathionine beta synthase

Diabetes mellitus (BASKET)

Diabetes mellitus (Involvement heart and vessels)

Diabetes mellitus (Involvement kidney)

Eclampsia

Endoglin

Endothelial dysfunction

Endothelial lipase

eNOS

ERS UFR (Pharmacology)

ERS UFR (Toxikologie)

Exercise (Physiology)

FLT1

Folic acid

Heart (Coronary heart disease BASKET)

Homocysteine

Insulin (BASKET)

Insulin (resistance)

Ion channel (TRP Family)

Ischemia reperfusion

Isoprostane

Kidney (Chronic renal failure)

Lipoprotein (OxLDL)

Metformin

NADPH oxidase

Nifedipine

Nitric oxide NO

Nitric oxide synthetase iNOS eNOS

Nitrosonifedipine

Olmesartan

PARP

PI3K

Preeclampsia

Pulmonary hypertension

RAAS (ACE inhibitor)

RAAS (Angiotensin receptor blockers)

Redox (BASKET)

Rho kinase

Sepsis

Sleep apnea (obstructive)

Sodium (Salt)

Statin

Tempol

Tetrahydrobiopterin

TGF beta

Thorax (Pain)

TRPV4

Von Willebrand s factor

Xanthine oxidase

2003  
1
Assessment of endothelial damage and dysfunction: observations in relation to heart failure.
[12651970] QJM 96(4): 253-67 (2003)
2006  
2
Recent advances in understanding endothelial dysfunction in atherosclerosis.
[16595793] Clin Med Res 4(1): 53-65 (2006)
2007  
3
Endothelial dysfunction in insulin resistance and type 2 diabetes.
[17645585] J Intern Med 262(2): 173-83 (2007)
2000  
4
Long-term use of angiotensin-converting enzyme inhibitors to modify endothelial dysfunction: a review of clinical investigations.
[10852664] Clin Invest Med 23(2): 144-61 (2000)
2004  
5
Physiology of the endothelium.
[15121728] Br J Anaesth 93(1): 105-13 (2004)
1993  
6
Integration of factors controlling vascular tone. Overview.
[8267212] Anesthesiology 79(6): 1368-80 (1993)
2003  
7
Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction?
[12720559] Crit Care 7(2): 130-8 (2003)
1992  
8
Endothelial vasomotor regulation in health and disease.
[1288910] Can J Anaesth 39(8): 838-57 (1992)
2005  
9
Childhood origins of endothelial dysfunction.
[16162614] Heart 91(10): 1272-4 (2005)
2005  
10
Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques.
[15772232] Heart 91(4): 553-8 (2005)
1997  
11
Non-invasive assessment of endothelial function.
[9155600] Heart 77(4): 297-8 (1997)
1994  
12
Endothelial dysfunction in heart failure and potential for reversal by ACE inhibition.
[7946797] Br Heart J 72(3 Suppl): S11-4 (1994)
1991  
13
St Cyres lecture. Endothelium in control.
[2015118] Br Heart J 65(3): 116-25 (1991)
2000  
14
Endothelial vasomotor dysfunction in hypertension.
[10962514] J Hum Hypertens 14(8): 481-3 (2000)
2000  
15
Endothelial dysfunction in arterial hypertension.
[10854076] J Hum Hypertens 14 Suppl 1(-): S20-5 (2000)
1997  
16
Coronary endothelial dysfunction in the hypertensive patient: from myocardial ischemia to heart failure.
[9111157] J Hum Hypertens 11(1): 45-9 (1997)
2010  
17
Novel mechanisms of endothelial dysfunction in diabetes.
[20877687] J Cardiovasc Dis Res 1(2): 59-63 (2010)
2008  
18
In search of understanding the endothelium.
[18698537] Cardiol J 15(4): 229-32 (2008)
2008  
19
Endothelial effects of antihypertensive treatment: focus on irbesartan.
[18629353] Vasc Health Risk Manag 4(1): 89-101 (2008)
2008  
20
Mechanisms of endothelial dysfunction in obstructive sleep apnea.
[19337546] Vasc Health Risk Manag 4(6): 1327-35 (2008)
2007  
21
Endothelial dysfunction in diabetes mellitus.
[18200806] Vasc Health Risk Manag 3(6): 853-76 (2007)
2005  
22
Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.
[17319104] Vasc Health Risk Manag 1(3): 183-98 (2005)
2005  
23
Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium.
[17319098] Vasc Health Risk Manag 1(1): 55-71 (2005)
2005  
24
Corticosteroids and endothelial dysfunction.
[17315598] Vasc Health Risk Manag 1(4): 261-2 (2005)
2003  
25
Molecular basis of endothelial dysfunction in sepsis.
[14522406] Cardiovasc Res 60(1): 49-57 (2003)
1999  
26
Oxidative stress, F2-isoprostanes and endothelial dysfunction in hypercholesterolemia.
[10690278] Cardiovasc Res 44(3): 474-6 (1999)
1999  
27
Homocysteine and endothelial function.
[10533596] Cardiovasc Res 42(3): 578-82 (1999)
1997  
28
Endothelial dysfunction and pathogenesis of diabetic angiopathy.
[9217873] Cardiovasc Res 34(1): 55-68 (1997)
2009  
29
Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?
[19187341] Br J Pharmacol 156(4): 545-62 (2009)
2000  
30
Endothelial dysfunction in diabetes.
[10882379] Br J Pharmacol 130(5): 963-74 (2000)
2001  
31
Disturbance of endothelial barrier function by bacterial toxins and atherogenic mediators: a role for Rho/Rho kinase.
[11580750] Cell Microbiol 3(10): 649-58 (2001)
2007  
32
Oxidative stress and endothelial dysfunction.
[17279271] Hamostaseologie 27(1): 5-12 (2007)
2006  
33
von Willebrand factor, endothelial dysfunction, and cardiovascular disease.
[16706957] J Thromb Haemost 4(6): 1186-93 (2006)
2001  
34
Oxidant stress and endothelial cell dysfunction.
[11245588] Am J Physiol Cell Physiol 280(4): C719-41 (2001)
2006  
35
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture).
[16632549] Am J Physiol Heart Circ Physiol 291(3): H985-1002 (2006)
2001  
36
Vascular endothelial dysfunction: does tetrahydrobiopterin play a role?
[11514262] Am J Physiol Heart Circ Physiol 281(3): H981-6 (2001)
2001  
37
Tetrahydrobiopterin: a critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction?
[11356602] Am J Physiol Heart Circ Physiol 280(6): H2484-8 (2001)
2005  
38
Endothelial cell dysfunction: can't live with it, how to live without it.
[15821252] Am J Physiol Renal Physiol 288(5): F871-80 (2005)
2006  
39
Endothelial dysfunction: a comprehensive appraisal.
[16504104] Cardiovasc Diabetol 5(-): 4 (2006)
2009  
40
Endothelial dysfunction: the first step toward coronary arteriosclerosis.
[19225203] Circ J 73(4): 595-601 (2009)
2007  
41
Endothelial function and dysfunction: testing and clinical relevance.
[17353456] Circulation 115(10): 1285-95 (2007)
2003  
42
2003  
43
Endothelial function testing as a biomarker of vascular disease.
[14581384] Circulation 108(17): 2054-9 (2003)
2001  
44
Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.
[11547217] Diabetes Metab 27(4 Pt 1): 436-47 (2001)
2001  
45
Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial function.
[11547216] Diabetes Metab 27(4 Pt 1): 425-34 (2001)
2008  
46
One step beyond: glutathione peroxidase and endothelial dysfunction.
[18299483] Hypertension 51(4): 825-6 (2008)
2008  
47
Oxidative stress, nitric oxide synthase, and superoxide dismutase: a matter of imbalance underlies endothelial dysfunction in the human coronary circulation.
[18071058] Hypertension 51(1): 31-2 (2008)
2007  
48
Methods for evaluating endothelial function in humans.
[17309954] Hypertension 49(4): 748-60 (2007)
2004  
49
2003  
50
The clinical implications of endothelial dysfunction.
[14522472] J Am Coll Cardiol 42(7): 1149-60 (2003)
1999  
51
Assessment and treatment of endothelial dysfunction in humans.
[10483941] J Am Coll Cardiol 34(3): 631-8 (1999)
1997  
52
Endothelial dysfunction: does it matter? Is it reversible?
[9247501] J Am Coll Cardiol 30(2): 325-33 (1997)
2009  
53
Vascular actions of insulin with implications for endothelial dysfunction.
[19491294] Am J Physiol Endocrinol Metab 297(3): E568-77 (2009)
2010  
54
Endothelial dysfunction and hypertension: cause or effect?
[20308609] Hypertension 55(5): 1092-4 (2010)
2010  
55
Arterial stiffness and endothelial function: key players in vascular health.
[20083729] Hypertension 55(3): 612-3 (2010)
2005  
56
Aldosterone promotes endothelial dysfunction via prostacyclin independent of hypertension.
[15956109] Hypertension 46(1): 29-30 (2005)
2006  
57
Endothelial dysfunction and the kidney: emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension.
[16565249] J Am Soc Nephrol 17(4 Suppl 2): S61-3 (2006)
2007  
58
A breakthrough in diabetic nephropathy: the role of endothelial dysfunction.
[17595179] Nephrol Dial Transplant 22(10): 2775-7 (2007)
2004  
59
Role of endothelial dysfunction in atherosclerosis.
[15198963] Circulation 109(23 Suppl 1): III27-32 (2004)
2004  
60
Endothelial dysfunction in pulmonary hypertension.
[14734504] Circulation 109(2): 159-65 (2004)
2003  
61
Clinical utility of endothelial function testing: ready for prime time?
[12835407] Circulation 107(25): 3243-7 (2003)
2005  
62
Childhood infection and endothelial dysfunction: a potential link in atherosclerosis?
[15811865] Circulation 111(13): 1568-70 (2005)
2009  
63
Molecular insights and therapeutic targets for diabetic endothelial dysfunction.
[19786641] Circulation 120(13): 1266-86 (2009)
2003  
64
Endothelial dysfunction: a marker of atherosclerotic risk.
[12588755] Arterioscler Thromb Vasc Biol 23(2): 168-75 (2003)
2004  
65
Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease.
[15243582] Cell Death Differ 11 Suppl 1(): S56-64 (2004)
2006  
66
Arterial endothelium and atherothrombogenesis II--the role of endothelial dysfunction in atherothrombotic lesions.
[17343105] Rev Port Cardiol 25(12): 1159-86 (2006)
2010  
67
From endothelial dysfunction to vascular occlusion: role of the renin-angiotensin system.
[20866008] Rev Port Cardiol 29(5): 801-24 (2010)
2009  
68
Endothelial function and atherosclerosis: circulatory markers with clinical usefulness.
[20058778] Rev Port Cardiol 28(10): 1121-51 (2009)
2008  
69
An integrated view of insulin resistance and endothelial dysfunction.
[18775359] Endocrinol Metab Clin North Am 37(3): 685-711, ix-x (2008)
2007  
70
Cardiovascular actions of insulin.
[17525361] Endocr Rev 28(5): 463-91 (2007)
2002  
71
Back to the salt mines-- endothelial dysfunction in hypertension and compensatory role of endothelium-derived hyperpolarizing factor (EDHF).
[12181276] J Physiol 543(Pt 1): 1 (2002)
2003  
72
New methods to evaluate endothelial function: method for assessing endothelial function in humans using a strain-gauge plethysmography: nitric oxide-dependent and -independent vasodilation.
[14737008] J Pharmacol Sci 93(4): 399-404 (2003)
2003  
73
New methods to evaluate endothelial function: Non-invasive method of evaluating endothelial function in humans.
[14737009] J Pharmacol Sci 93(4): 405-8 (2003)
2003  
74
New methods to evaluate endothelial function: Evaluation of endothelial function by hemoglobin-nitric oxide complex using electron paramagnetic resonance spectroscopy.
[14737011] J Pharmacol Sci 93(4): 417-22 (2003)
2009  
75
Drug discovery for overcoming chronic kidney disease (CKD): development of drugs on endothelial cell protection for overcoming CKD.
[19151535] J Pharmacol Sci 109(1): 14-9 (2009)
2009  
76
Endothelium-dependent contractions and endothelial dysfunction in human hypertension.
[19630832] Br J Pharmacol 157(4): 527-36 (2009)
2011  
77
Tea consumption enhances endothelial-dependent vasodilation; a meta-analysis.
[21394199] PLoS One 6(3): e16974 (2011)
2011  
78
Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction.
[20712407] Antioxid Redox Signal 15(4): 933-48 (2011)
2008  
79
Oxidative stress impairs endothelial progenitor cell function.
[18627346] Antioxid Redox Signal 10(11): 1895-907 (2008)
2005  
80
Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme.
[16356120] Antioxid Redox Signal 7(11-12): 1568-80 (2005)
2003  
81
Endothelial dysfunction in preeclampsia and eclampsia: current etiology and future non-invasive assessment.
[14719469] Isr Med Assoc J 5(10): 724-6 (2003)
2003  
82
Endothelial dysfunction: a crystal ball prediction for enhanced cardiovascular risk?
[14719473] Isr Med Assoc J 5(10): 736-8 (2003)
2006  
83
Endothelial dysfunction in pre-eclampsia.
[17332674] Pharmacol Rep 58 Suppl(-): 69-74 (2006)
2006  
84
Clinical aspects of assessment of endothelial function.
[17332669] Pharmacol Rep 58 Suppl(-): 33-40 (2006)
2008  
85
Endothelium in health and disease.
[18276995] Pharmacol Rep 60(1): 139-43 (2008)
2008  
86
Endothelial dysfunction in heart failure.
[18276993] Pharmacol Rep 60(1): 119-26 (2008)
2008  
87
NADPH oxidase-derived reactive oxygen species in the regulation of endothelial phenotype.
[18276982] Pharmacol Rep 60(1): 21-8 (2008)
2011  
88
Variant angina associated with coronary artery endothelial dysfunction and myocardial bridge: a case report and review of the literature.
[22041365] Intern Med 50(21): 2601-6 (2011)
2005  
89
Endothelial function and coronary spastic angina.
[15750267] Intern Med 44(2): 91-9 (2005)
2009  
90
Risk prediction in cardiovascular disease: the prognostic significance of endothelial dysfunction.
[19521569] Can J Cardiol 25 Suppl A(-): 15A-20A (2009)
2009  
91
Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress.
[19436671] Vasc Health Risk Manag 5(1): 265-72 (2009)
2009  
92
Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomil.
[19436655] Vasc Health Risk Manag 5(1): 301-14 (2009)
2007  
93
Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial Programme.
[17583170] Vasc Health Risk Manag 3(1): 1-9 (2007)
2008  
94
Measurement of endothelial function and its clinical utility for cardiovascular risk.
[18827914] Vasc Health Risk Manag 4(3): 647-52 (2008)
2009  
95
Human endothelial function and microvascular ageing.
[19042980] Exp Physiol 94(3): 311-6 (2009)
2010  
96
Physical exercise and endothelial dysfunction.
[21225112] Arq Bras Cardiol 95(5): e130-7 (2010)
2010  
97
Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus.
[20634940] Mediators Inflamm 2010(-): 792393 (2010)
2009  
98
Vascular consequences of dietary salt intake.
[19339634] Am J Physiol Renal Physiol 297(2): F237-43 (2009)
2009  
99
Asymmetric dimethylarginine (ADMA) and endothelial dysfunction: implications for atherogenesis.
[19488614] Clinics (Sao Paulo) 64(5): 471-8 (2009)
2009  
100
Endothelial dysfunction as a target for prevention of cardiovascular disease.
[19875572] Diabetes Care 32 Suppl 2(-): S314-21 (2009)
2011  
101
Angiogenic factors and preeclampsia.
[21266263] Semin Nephrol 31(1): 33-46 (2011)
2009  
102
Assessment of endothelial function: implications for hypertension and cardiovascular disorders.
[19505269] Expert Rev Cardiovasc Ther 7(6): 561-3 (2009)
2010  
103
Activation of AMP-activated protein kinase inhibits oxidized LDL-triggered endoplasmic reticulum stress in vivo.
[20299472] Diabetes 59(6): 1386-96 (2010)
2012  
104
Endothelial dysfunction in diabetes mellitus: possible involvement of endoplasmic reticulum stress?
[22474423] Exp Diabetes Res 2012(): 481840 (2012)
2007  
105
TRP channels in endothelial function and dysfunction.
[17434294] Biochim Biophys Acta 1772(8): 907-14 (2007)
2008  
106
Systemic activation of the transient receptor potential vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: Part 2.
[18499744] J Pharmacol Exp Ther 326(2): 443-52 (2008)
2009  
107
Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects.
[19042039] Trends Pharmacol Sci 30(1): 48-54 (2009)
2007  
108
Endothelial dysfunction in obstructive sleep apnea.
[17694731] J Clin Sleep Med 3(4): 409-15 (2007)
2010  
109
Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.
[20186491] Rev Endocr Metab Disord 11(1): 61-74 (2010)
2008  
110
The role of inflammatory cytokines in endothelial dysfunction.
[18600364] Basic Res Cardiol 103(5): 398-406 (2008)
2010  
111
Diagnosis and treatment of endothelial dysfunction in cardiovascular disease.
[20145343] Int Heart J 51(1): 1-6 (2010)
2009  
112
High-dose folic acid supplementation effects on endothelial function and blood pressure in hypertensive patients: a meta-analysis of randomized controlled clinical trials.
[19646382] J Chiropr Med 8(1): 15-24 (2009)
2010  
113
The role of RhoA/Rho kinase pathway in endothelial dysfunction.
[21264179] J Cardiovasc Dis Res 1(4): 165-70 (2010)
2011  
114
Endothelial dysfunction in cardiovascular and endocrine-metabolic diseases: an update.
[21956535] Braz J Med Biol Res 44(9): 920-32 (2011)
2011  
115
Endothelial Dysfunction in the Apolipoprotein E-deficient Mouse: insights into the influence of diet, gender and aging.
[22082357] Lipids Health Dis 10(-): 211 (2011)
2010  
116
The role of caveolae in endothelial cell dysfunction with a focus on nutrition and environmental toxicants.
[20406324] J Cell Mol Med 14(10): 2359-70 (2010)
2004  
117
Endothelial dysfunction and reactive oxygen species production in ischemia/reperfusion and nitrate tolerance.
[15638116] Gen Physiol Biophys 23(3): 265-95 (2004)
2011  
118
Nitric oxide: a key factor behind the dysfunctionality of endothelial progenitor cells in diabetes mellitus type-2.
[21186243] Cardiovasc Res 91(1): 9-15 (2011)
2010  
119
Simply say yes to NO? Nitric oxide (NO) sensor-based assessment of coronary endothelial function.
[20736240] Eur Heart J 31(23): 2834-6 (2010)
2011  
120
Stiff endothelial cell syndrome in vascular inflammation and mineralocorticoid excess.
[21149825] Hypertension 57(2): 146-7 (2011)
PMC   
121
Transcriptional regulation of endothelial dysfunction in atherosclerosis: an epigenetic perspective.
[24474963] J Biomed Res 28(1):47-52 (2014)
PMC   
122
Linking endothelial dysfunction with endothelial cell activation.
[23485580] J Clin Invest 123(2):540-1 (2013)
PMC   
123
L-carnitine preserves endothelial function in a lamb model of increased pulmonary blood flow.
[23628882] Pediatr Res 74(1):39-47 (2013)
PMC   
124
The inter-arm diastolic blood pressure difference induced by one arm ischemia: a new approach to assess vascular endothelia function.
[24454748] PLoS One 9(1):e84765 (2014)
PMC   
125
alpha-Melanocyte-stimulating hormone regulates vascular NO availability and protects against endothelial dysfunction.
[23131503] Cardiovasc Res 97(2):360-8 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Endothelial dysfunction.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Endothelial dysfunction.php on line 92